Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
DexTech Medical | DEX | 15. mai 2024 | 4.40 | -3.51 |
Diagonal Bio | DIABIO | 15. mai 2024 | 0.03 | -46.80 |
Diamyd Medical B | DMYDB | 15. mai 2024 | 13.18 | +14.61 |
Dicot | DICOT | 15. mai 2024 | 0.26 | +0.20 |
Double Bond Pharmaceutical B | DBPB | 15. mai 2024 | 0.70 | -3.33 |
Ectin Research | ECTINB | 15. mai 2024 | 0.45 | -2.62 |
Egetis Therapeutics | EGTX | 15. mai 2024 | 6.72 | +9.62 |
Elicera Therapeutics | ELIC | 15. mai 2024 | 0.85 | -5.12 |
Ellen | ELN | 15. mai 2024 | 1.44 | +4.35 |
Enorama Pharma | ERMA | 15. mai 2024 | 3.50 | +0.29 |
Enzymatica | ENZY | 15. mai 2024 | 3.20 | -1.54 |
EQL Pharma | EQL | 15. mai 2024 | 43.40 | +8.50 |
Eurocine Vaccines | EUCI | 15. mai 2024 | 0.04 | -5.24 |
ExpreS2ion Biotech Holding | EXPRS2 | 15. mai 2024 | 1.44 | -0.14 |
Fluicell | FLUI | 15. mai 2024 | 0.09 | -2.75 |
Gabather | GABA | 15. mai 2024 | 2.11 | -3.21 |
Genovis | GENO | 15. mai 2024 | 31.95 | +9.61 |
Glycorex Transplantati.. | GTABB | 15. mai 2024 | 0.98 | -1.41 |
Guard Therapeutics International | GUARD | 15. mai 2024 | 39.00 | +1.56 |
Hamlet BioPharma AB (publ) | HAMLETB | 15. mai 2024 | 4.20 | +3.19 |
Hansa Biopharma | HNSA | 15. mai 2024 | 38.00 | +1.33 |
Hemply Balance | HMPLY | 15. mai 2024 | 0.03 | -14.29 |
I-tech | ITECH | 15. mai 2024 | 48.20 | -0.21 |
Immunovia | IMMNOV | 15. mai 2024 | 1.55 | +1.84 |
InDex Pharmaceuticals Holding | INDEX | 15. mai 2024 | 0.41 | +1.22 |
Infant Bacterial Therapeutics B | IBTB | 15. mai 2024 | 97.80 | -1.21 |
Initiator Pharma | INIT | 15. mai 2024 | 9.30 | -0.64 |
Intervacc | IVACC | 15. mai 2024 | 4.37 | -7.02 |
IRLAB Therapeutics A | IRLABA | 15. mai 2024 | 15.75 | -2.78 |
Isofol Medical | ISOFOL | 15. mai 2024 | 0.70 | +0.14 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.